Léim chuig an ábhar
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Teanga
Gach réimse
Teideal
Údar
Ábhar
Gairmuimhir
ISBN/ISSN
Clib
AIMSIGH
CASTA
Effect of Valsartan on the Inc...
Luaigh é seo
Seol mar théacs é seo
Seol é seo mar r-phost
Priontáil
Easpórtáil taifead
Easpórtáil chuig RefWorks
Easpórtáil chuig EndNoteWeb
Easpórtáil chuig EndNote
Buan-nasc
Effect of Valsartan on the Incidence of Diabetes REPLY
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:
Holman, R
,
Holzhauer, B
,
McMurray, J
Formáid:
Journal article
Foilsithe / Cruthaithe:
2010
Stoc
Cur síos
Míreanna comhchosúla
Amharc foirne
Míreanna comhchosúla
Effect of valsartan on the incidence of diabetes and cardiovascular events.
de réir: McMurray, J, et al.
Foilsithe / Cruthaithe: (2010)
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
de réir: Currie, G, et al.
Foilsithe / Cruthaithe: (2017)
The authors reply
de réir: Holman, R, et al.
Foilsithe / Cruthaithe: (2010)
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
de réir: Krum, H, et al.
Foilsithe / Cruthaithe: (2010)
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
de réir: Califf, R, et al.
Foilsithe / Cruthaithe: (2008)